ABLE Human Motion S.L.

ABLE Human Motion S.L. is a Spanish medical device company based in Barcelona that designs, manufactures, sells and maintains robotic exoskeletons for neurorehabilitation. According to its own materials, the company's mission is to democratise access to exoskeleton technology so that people with mobility impairments can rehabilitate, move and live with greater independence. Its flagship product, the ABLE Exoskeleton, is a lightweight, fast-to-don robotic device intended for clinical neurorehabilitation settings, where it actively assists people with mobility problems to walk again. The company positions itself around accessibility and usability. It highlights a physiological gait pattern intended to help retrain the brain and muscles, a donning time of under six minutes to maximise therapy time, intuitive and versatile use adapted to each patient, and a price and design philosophy aimed at making robotic rehabilitation broadly available to clinics rather than only to a few large centres. ABLE states that its exoskeleton has helped more than 500 people with neurological disabilities take more than 2,000,000 steps, and that the device has been validated in reference neurorehabilitation hospitals in Germany, the Netherlands, the United Kingdom and Spain, with clinical results published in high-impact scientific journals. ABLE Human Motion describes itself as a start-up and a medical device manufacturer. Its team designs, manufactures, sells and maintains its products for customers across the European Union. The organisation holds ISO 13485 quality certification, which it presents as evidence that its exoskeletons are manufactured under demanding standards for medical devices. The company also states that it is a member of relevant professional societies in its field. Culturally and operationally, ABLE emphasises inclusion, quality and purpose-driven engineering. Its recruitment messaging seeks engineers "with a purpose" and frames the company's goal as turning disability into ability. The company is privately held and, as of the available evidence, does not disclose a parent company, founder names or a founding year in the supplied sources. Its public identity is therefore that of an independent Barcelona medtech venture commercialising a clinical rehabilitation exoskeleton across Europe.

ABLE Human Motion S.L. is a Barcelona-based medical device company that develops robotic exoskeleton technology for neurorehabilitation. The available evidence describes it as a start-up and a medical device manufacturer whose team designs, manufactures, sells and maintains its products for customers throughout the European Union. The company presents itself as pioneering lightweight, fast-to-adjust and accessible robotic exoskeletons for rehabilitation, with the stated mission of democratising access to this technology and improving the rehabilitation, health and quality of life of people with reduced mobility. From its base in Barcelona, ABLE Human Motion has focused its commercial and clinical efforts on the European market. Its flagship ABLE Exoskeleton is positioned for clinical neurorehabilitation environments, where it actively assists people with mobility problems to walk again. The company reports that the device has been validated in reference neurorehabilitation hospitals in Germany, the Netherlands, the United Kingdom and Spain, and that clinical results showing improvements in gait training tolerance, motor function and quality of life have been published in high-impact scientific journals. It also states that the exoskeleton has helped more than 500 people with neurological disabilities take more than 2,000,000 steps. Operationally, ABLE Human Motion emphasises quality and regulatory compliance appropriate to medical devices. The organisation has obtained ISO 13485 certification, which it says ensures that its exoskeletons are manufactured under the most demanding standards for health products. It also states that it is a member of relevant professional societies in its field. The company's public messaging stresses inclusion, diversity and equality as drivers of innovation, and its recruitment materials describe a passionate team building a cutting-edge technology company with the aim of turning disability into ability. The supplied evidence does not specify a founding year, founder names, ownership structure or funding history. What is clear is that ABLE Human Motion operates as an independent, privately held medtech venture headquartered in Barcelona, selling and supporting its exoskeleton products across the European Union and validating them through clinical partnerships in several European countries.

• ABLE Human Motion is described as a Barcelona-based medical device company developing robotic exoskeleton technology for neurorehabilitation.

• The ABLE Exoskeleton is validated in reference neurorehabilitation hospitals in Germany, the Netherlands, the United Kingdom and Spain.

• The company reports that its exoskeleton has helped more than 500 people with neurological disabilities take more than 2,000,000 steps.

• ABLE Human Motion obtains ISO 13485 quality certification for medical device manufacturing.

Accessible, lightweight and fast-to-don robotic exoskeleton technology for clinical neurorehabilitation, designed to democratise access to robotic rehabilitation.

• ABLE Exoskeleton

  A lightweight, fast-to-adjust robotic exoskeleton for clinical neurorehabilitation that actively assists people with mobility problems to walk again. It features a physiological gait pattern, donning in under six minutes, intuitive and versatile use, and an accessible design aimed at broad clinic adoption.

1. 1Exoesqueletos Rehabilitación | Diseño y Fabricaciónablehumanmotion.com
2. 2¿Quiénes somos? | ABLE Human Motionablehumanmotion.com
3. 3Trabaja con nosotros | ABLE Human Motionablehumanmotion.com
4. 4ABLE Human Motion S.L. (Spain) - Wikidatawikidata.org